Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
New Products Fuel Q3 Growth
On November 1, Dorman Products announced earnings of 54 cents per share for the third quarter, outpacing the Zacks Consensus Estimate of 47 cents by 14.9%. It also beat last years 41 cents.
Revenues grew 20% to $156.4 million, driven mainly by burgeoning demand for its products. The company generated higher revenues from recently launched products as it has introduced roughly 2,500 new parts in 2012, including over 630 dealer-only parts.
Gross margin increased to 38.2% from 37.2% in the year-ago quarter. The increase was attributable to a favorable change in sales mix, lower transportation costs and lower provisions for excess and obsolete inventory.
Earnings Momentum on an Upswing
The Zacks Consensus Estimate for 2012 went up 2.8% to $1.85 per share in the past 30 days, driven by upward revisions from two of three estimates. For 2013, the Zacks Consensus Estimate is up 4.3% to $2.17 based again on upward revisions from two of three estimates. The estimates for 2012 and 2013 suggest year-over-year growth of 20.7% and 17.1%, respectively.
Expensive Yet Justified Valuation
Valuation of Dorman Products looks expensive. The price-to-book of 3.1x is at a significant premium of 121.4% compared to the peer group average of 1.4x. Its price-to-sales (P/S) ratio of 2.0 is also at a considerable premium with respect to its peer group average of 0.6. However, the company has a higher 1-year ROE of 19.3% compared to the peer group average of 11.2%. The expensive valuation is justified given the companys strong product lineups and continuous improvement in retail sales environment.
Impressive Chart
The stock started outperforming its 50-day and 200-day moving averages from the fourth quarter of 2011. It is currently moving sideways with 50-day moving average, which stands at $31.00.
Incorporated in1978 and headquartered in Colmar, Pennsylvania, Dorman Products is a supplier of automotive replacement parts and fasteners and service line products for the automotive aftermarket. The company offers nearly 128,000 different automotive replacement parts, fasteners and service line products, primarily in the U.S. through renowned aftermarket retailers including AutoZone Inc. (AZO), Advance Auto Parts Inc. (AAP), and OReilly Automotive Inc. (ORLY); national, regional and local warehouse distributors such as Carquest and NAPA; and specialty markets and salvage yards. It also distributes its products to international locations such as Europe, Mexico, the Middle East, Asia and Canada.
Want More of Our Best Recommendations?
Zacks' Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Then each week he hand-selects the most compelling trades and serves them up to you in a new program called Zacks Confidential.
Learn More>>
Read the full reports :
Snapshot Report on DORM